Target intelligence / Profile preview

Natural Killer Cell (None)

Target
None
Molecular classification
Cytotoxic lymphocyte, Innate immune cell
01

Overview

Natural killer cells (NK cells) are cytotoxic lymphocytes of the innate immune system that provide rapid responses to virus-infected and malignant cells. Their activity is regulated by a balance of activating and inhibitory receptor signals. NK cells kill target cells through the release of lytic granules and cytokine secretion, and they mediate antibody-dependent cellular cytotoxicity (ADCC).

02

Mechanism of action

NK cells recognize and kill target cells through a balance of activating and inhibitory receptor signals. Activating receptors recognize stress-induced ligands, while inhibitory receptors recognize MHC-I. Lack of MHC-I or strong activating signals trigger the release of cytotoxic granules containing perforin and granzymes, leading to target cell apoptosis. CD16 (FcγRIIIa) mediates ADCC.

03

Biological functions

CytolysisCytokine productionInnate immunityAntibody-dependent cellular cytotoxicity (ADCC)
04

Disease associations

Viral infectionCancerImmunodeficiency
05

Safety considerations

Cytokine release syndrome (CRS)Graft-versus-host disease (GvHD) (in allogeneic NK cell therapies)Off-target toxicity
06

Interacting drugs

Interleukins (e.g., IL-2, IL-15)

3 more in the full profile.

07

Biomarkers

NK cell numberNK cell activity (cytotoxicity assays)Expression of activating and inhibitory receptors (e.g., NKG2D, KIRs, CD16)Cytokine production (e.g., IFN-γ, TNF-α)

Beyond the preview

Go deeper on Natural Killer Cell (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Killer Cell (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call